Eagle Boston Investment Management Inc buys $12,490,860 stake in Merit Medical Systems (MMSI)

Merit Medical Systems (MMSI) : Eagle Boston Investment Management Inc scooped up 15,379 additional shares in Merit Medical Systems during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 581,782 shares of Merit Medical Systems which is valued at $12,490,860.Merit Medical Systems makes up approximately 1.63% of Eagle Boston Investment Management Inc’s portfolio.

Other Hedge Funds, Including , Eagle Asset Management Inc boosted its stake in MMSI in the latest quarter, The investment management firm added 10,196 additional shares and now holds a total of 91,726 shares of Merit Medical Systems which is valued at $1,969,357. Merit Medical Systems makes up approx 0.01% of Eagle Asset Management Inc’s portfolio.Dalton Greiner Hartman Maher Co boosted its stake in MMSI in the latest quarter, The investment management firm added 100,343 additional shares and now holds a total of 1,118,892 shares of Merit Medical Systems which is valued at $23,407,221. Merit Medical Systems makes up approx 1.40% of Dalton Greiner Hartman Maher Co’s portfolio.Capstone Asset Management Co boosted its stake in MMSI in the latest quarter, The investment management firm added 2,280 additional shares and now holds a total of 18,770 shares of Merit Medical Systems which is valued at $392,668. Merit Medical Systems makes up approx 0.01% of Capstone Asset Management Co’s portfolio.Cutler Group Lp boosted its stake in MMSI in the latest quarter, The investment management firm added 3,937 additional shares and now holds a total of 4,230 shares of Merit Medical Systems which is valued at $88,492. Merit Medical Systems makes up approx 0.01% of Cutler Group Lp’s portfolio. New England Research Management added MMSI to its portfolio by purchasing 20,840 company shares during the most recent quarter which is valued at $415,550. Merit Medical Systems makes up approx 0.36% of New England Research Management’s portfolio.

Merit Medical Systems opened for trading at $21.37 and hit $21.55 on the upside on Wednesday, eventually ending the session at $21.47, with a gain of 1.08% or 0.23 points. The heightened volatility saw the trading volume jump to 2,59,121 shares. Company has a market cap of $951 M.

On the company’s financial health, Merit Medical Systems reported $0.19 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.17. The company had revenue of $138.10 million for the quarter, compared to analysts expectations of $137.96 million. The company’s revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.18 EPS.

Merit Medical Systems Inc. (Merit) is a designer developer manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures across the world. The Company operates in the diagnostic and interventional cardiology interventional radiology interventional gastroenterology interventional pulmonology thoracic surgery interventional nephrology vascular surgery oncology electrophysiology cardiac rhythm management and pain management markets. It operates in segments: cardiovascular and endoscopy. Its cardiovascular segment comprises cardiology and radiology devices which assist in diagnosing and treating coronary arterial disease peripheral vascular disease and other non-vascular diseases and includes the embolotherapeutic products. Its endoscopy segment comprises gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal tracheobronchial and biliary strictures caused by malignant tumors.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *